Thursday, March 17, 2016

Oncogene - Table of Contents alert Volume 35 Issue 11

If you are unable to see the message below, click here to view.
Oncogene

Advertisement
The Return of the ChIP Kit

With Diagenode's ChIP Kit Customizer, buy only the kit-quality reagents that you want.
  • Buy only what you need! Select from individual components or full kits
  • Validated, ChIP-grade reagents including buffers, beads, controls, antibodies, and more!

Learn more.


TABLE OF CONTENTS

Volume 35, Issue 11 (March 2016)

In this issue
Review
Original Articles
Meeting Report
Short Communications

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Oncogenesis Focus Collection: Cancer & Metabolism

While extremely diverse in origin, all cancer cells show profound metabolic changes. The articles in this Special Issue discuss the connection between cancer cells and their metabolic adaptations, from molecular mechanisms to anticancer therapies, and highlight the dialogue between whole organism and cancer cells.

Explore the Special Issue in full.

Review

Top

Context-dependent actions of Polycomb repressors in cancer

M Koppens and M van Lohuizen

Oncogene 2016 35: 1341-1352; advance online publication, June 8, 2015; 10.1038/onc.2015.195

Abstract | Full Text

Original Articles

Top

Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells

E Dickreuter, I Eke, M Krause, K Borgmann, M A van Vugt and N Cordes

Oncogene 2016 35: 1353-1362; advance online publication, June 15, 2015; 10.1038/onc.2015.212

Abstract | Full Text

RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression

Y Wang, O Deng, Z Feng, Z Du, X Xiong, J Lai, X Yang, M Xu, H Wang, D Taylor, C Yan, C Chen, A Difeo, Z Ma and J Zhang

Oncogene 2016 35: 1363-1372; advance online publication, August 3, 2015; 10.1038/onc.2015.198

Abstract | Full Text

Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism OPEN

C R Goodman, T Sato, A R Peck, M A Girondo, N Yang, C Liu, A F Yanac, A J Kovatich, J A Hooke, C D Shriver, E P Mitchell, T Hyslop and H Rui

Oncogene 2016 35: 1373-1385; advance online publication, June 22, 2015; 10.1038/onc.2015.193

Abstract | Full Text

Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers OPEN

E Marques, J I Englund, T A Tervonen, E Virkunen, M Laakso, M Myllynen, A Mäkelä, M Ahvenainen, T Lepikhova, O Monni, S Hautaniemi and J Klefström

Oncogene 2016 35: 1386-1398; advance online publication, June 15, 2015; 10.1038/onc.2015.196

Abstract | Full Text

p54nrb/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A

Z Zhu, X Zhao, L Zhao, H Yang, L Liu, J Li, J Wu, F Yang, G Huang and J Liu

Oncogene 2016 35: 1399-1410; advance online publication, July 6, 2015; 10.1038/onc.2015.197

Abstract | Full Text

Glioma invasion mediated by the p75 neurotrophin receptor (p75NTR/CD271) requires regulated interaction with PDLIM1 OPEN

B Y Ahn, R F G Saldanha-Gama, J J Rahn, X Hao, J Zhang, N-H Dang, M Alshehri, S M Robbins and D L Senger

Oncogene 2016 35: 1411-1422; advance online publication, June 29, 2015; 10.1038/onc.2015.199

Abstract | Full Text

Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors

A P Berbegall, E Villamón, M Piqueras, I Tadeo, A Djos, P F Ambros, T Martinsson, I M Ambros, A Cañete, V Castel, S Navarro and R Noguera

Oncogene 2016 35: 1423-1432; advance online publication, June 29, 2015; 10.1038/onc.2015.200

Abstract | Full Text

OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance OPEN

U Karunarathna, M Kongsema, S Zona, C Gong, E Cabrera, A R Gomes, E P S Man, P Khongkow, J W-H Tsang, U-S Khoo, R H Medema, R Freire and E W-F Lam

Oncogene 2016 35: 1433-1444; advance online publication, July 6, 2015; 10.1038/onc.2015.208

Abstract | Full Text

Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment

A Deguchi, T Tomita, U Ohto, K Takemura, A Kitao, S Akashi-Takamura, K Miyake and Y Maru

Oncogene 2016 35: 1445-1456; advance online publication, July 13, 2015; 10.1038/onc.2015.211

Abstract | Full Text

Meeting Report

Top

From zero to sixty: cell death signaling in the city that never sleeps

J D Gelles, R Elkholi, M N Serasinghe, M P A Luna-Vargas and J E Chipuk

Oncogene 2016 35: 1457-1460; advance online publication, July 6, 2015; 10.1038/onc.2015.194

Full Text

Short Communications

Top

Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress

S M Hein, S Haricharan, A N Johnston, M J Toneff, J P Reddy, J Dong, W Bu and Y Li

Oncogene 2016 35: 1461-1467; advance online publication, June 22, 2015; 10.1038/onc.2015.206

Abstract | Full Text

Runx1 contributes to neurofibromatosis type 1 neurofibroma formation

H Li, X Zhao, X Yan, W J Jessen, M-O Kim, E Dombi, P P Liu, G Huang and J Wu

Oncogene 2016 35: 1468-1474; advance online publication, June 15, 2015; 10.1038/onc.2015.207

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: